Quantcast

Latest Virtual Karyotype Stories

2008-09-30 06:00:33

MUKILTEO, Wash., Sept. 30, 2008 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today the launch of two new array-based diagnostic tests, adding to its leading and growing portfolio of tests. These new tests augment each other and demonstrate levels of multiplexing and personalization that are unprecedented in the industry. The tests will be operated out of its wholly owned laboratory in Irvine, California, CombiMatrix Molecular Diagnostics. The first test is an update...

2008-08-18 12:00:55

Researchers at Signature Genomic Laboratories recently published the first large-scale prospective study comparing the detection rate of chromosomal abnormalities--missing or extra pieces of DNA--by microarray analysis in prenatal cases to that of neonatal cases referred with a variety of clinical findings, including congenital anomalies. In the study, the findings of which will appear in the September issue of the journal Prenatal Diagnosis and were electronically published July 22,...

2008-08-12 06:01:05

MUKILTEO, Wash., Aug. 12, 2008 (PRIME NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that a retrospective, clinical validation study of its test for Chronic Lymphocytic Leukemia (CLL) is to be published in the September issue of the Journal of Molecular Diagnostics (J Mol Diagn 2008, 10:442-451). This publication augments an earlier publication in the Expert Opinions in Molecular Diagnostics ((2008) 2(6): 1-10). Dr. Shelly Gunn, M.D., Ph.D. Medical Director of CombiMatrix...

2008-07-30 09:00:23

Chromosomal rearrangements leading to genomic disorders are often mediated by low-copy repeat regions of the genome (e.g. segmental duplications). Roche NimbleGen CGH arrays offer expanded probe coverage in these regions. Using this technique, the authors of a recently published paper(1) identified a recurrent reciprocal genomic rearrangement of chromosomal region 17q12 in fetal samples with congenital anomalies that is also associated with pediatric renal disease and epilepsy. The results...

2008-01-16 03:00:13

By Yip, Stephen Iafrate, A John; Louis, David N Abstract Advances in understanding the molecular underpinnings of cancer and in molecular diagnostic technologies have changed the clinical practice of oncologic pathology. The development of targeted therapies against specific molecular alterations in cancer further portends changes in the role of the pathology laboratory to guide such custom therapies. To reconcile the flood of scientific discoveries in this area, the promises of highly...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related